Cogent Biosciences Inc (COGT) — Cash Flow Quality Index
Latest as of December 2019:
-3.68x
Cogent Biosciences Inc (COGT) has a Cash Flow Quality Index of -3.68x as of December 2019. Operating cash flow of $-8.45 Million is below net income of $2.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cogent Biosciences Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-3.68x
Operating CF / Net Income
Operating Cash Flow
$-8.45 Million
USD
Net Income
$2.30 Million
USD
Data as of
Dec 2019
Most recent filing
Annual Cash Flow Quality Index for Cogent Biosciences Inc (None–None)
Year-by-year earnings quality comparison for Cogent Biosciences Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.